Xoma Royalty (XOMA) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Competitors, else..
 
Xoma Royalty Corporation  (NASDAQ: XOMA)
 

Xoma Royalty Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

XOMA Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) -22.59 % 12.24 % 9.19 % 10.9 %
Q / Q Revenue Growth (Q1 MRQ) -10.46 % -2.93 % -3.28 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 13.16 % 9.25 % 7.99 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) -6.89 % 2.69 % 2.09 % 2.61 %
Revenue 5 Year Average Growth 12.16 % 7.41 % 8.65 % 10.59 %


XOMA's Growth Comparisons in I. Quarter 2026




Xoma Royalty's sharp decrease of -22.59% in sales in the first quarter from the same quarter a year ago, those results deviated strongly from rising Revenue in Major Pharmaceutical Preparations industry with 12.24%, and underperformed the 9.19% Revenue growth in the Healthcare sector. Comparing the first quarter, sales Xoma Royalty Corporation was trailing overall market not just Major Pharmaceutical Preparations industry.

Sequentially company's Revenue fell by -10.46% from the fourth quarter results. . Looking into annual growth, sales grew by 12.16% on average in last five years, while S & P 500's including only Businesses with the first quarter 2026 earnings reports, average yearly sales growth is 10.59%.

XOMA Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Single Reportable Segment
-22.59 %
-
United States
-7.76 %
-
Switzerland
15.11 %
-
Total
-22.59 %
-76.38 %


Growth Rates of XOMA's Income in the first quarter 2026


XOMA Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) - -8.69 % 5.13 % 97.6 %
Sequential Operating Income Change (Q1 MRQ) - -4.52 % 0.89 % 48.13 %
Y / Y Operating Income Growth (Q1 TTM) - 30.72 % 30.96 % 40.67 %
Sequential Operating Income Growth (Q1 TTM) -56.3 % -2.28 % 4.91 % 20.86 %
Operating Income 5 Year Avg. Change - 14.39 % 10.39 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) 200.85 % -34.78 % -25.81 % 90.69 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) -90.91 % -2.61 % -66.16 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) 836.79 % 6.22 % 9.85 % 57.33 %
Sequential Income from Cont. Ops. Change (Q1 TTM) 3.67 % -10.03 % -4.69 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change - -0.55 % 0.17 % -28.52 %

XOMA Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) 200.85 % -35.13 % -26.29 % 90.69 %
Q / Q Net Income Growth (Q1 MRQ) -35.88 % 2.8 % -0.86 % 27.07 %
Y / Y Net Income Change (Q1 TTM) - 5.2 % 15.48 % 57.33 %
Sequential Net Income Change (Q1 TTM) 7.65 % -10.18 % -6.71 % 18.65 %
Net Income 5 Year Avg. Growth - 14.55 % 9.21 % 22.96 %

XOMA's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) 200 % -40.16 % -25.81 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) -33.33 % -7.73 % -66.16 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) 7.84 % - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth 13.29 % -10.82 % 0.17 % -28.52 %



XOMA EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) 183.33 % -40.49 % -26.29 % -28.52 %
Q / Q EPS Net Growth (Q1 MRQ) -5.56 % -2.61 % -0.86 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) 7.97 % -7.05 % -4.12 % 4.93 %
EPS Net 5 Year Avg. Change 13.36 % 14.55 % 9.21 % 22.96 %



Despite the -40.49% decline in Major Pharmaceutical Preparations industry, Xoma Royalty showed impressive surge in EPS in the first quarter by 183.33% from the same quarter a year ago, to $0.17, Healthcare sector dropped -26.29%. Despite modest earnings per share in the Major Pharmaceutical Preparations industry and ind the Healthcare sector, Xoma Royalty Corporation reported above average market earnings per share growth.

the bottom-line fell by -5.56% from the fourth quarter. Average annual income per share growth for Xoma Royalty is 13.36%, while S & P 500's average yearly income per share increase is 22.96%, including only Businesses with the first quarter 2026 earnings.

XOMA Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) 178.48 % 25.53 % 48.48 % 48.62 %
Sequential Free Cash Flow Change (Q1 MRQ) - -42.35 % -46.96 % 34.18 %
Y / Y Free Cash Flow Change (Q1 TTM) - 12.28 % 19.59 % 60.27 %
Sequential Free Cash Flow Change (Q1 TTM) - 3.34 % 5.76 % 15.75 %
Free Cash Flow 5 Year Avg. Change - 1.86 % 0.92 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q1 MRQ) 59.42 % - - 216.68 %
Y / Y Net Cash Flow Change (Q1 TTM) - - - 209.43 %
Sequential Net Cash Flow Change (Q1 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change -1.66 % 29.88 % 6.46 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) - 11.25 % 8.23 % 120.03 %
Sequential Capital Expenditures Change (Q1 MRQ) - -25.6 % -22.09 % 36.87 %
Y / Y Capital Expenditures Change (Q1 TTM) 2.71 % 16.46 % 7.77 % 109.38 %
Sequential Capital Expenditures Change (Q1 TTM) 0 % 2.81 % 1.52 % 23.05 %
Capital Expenditures 5 Year Avg. Change - 7.84 % 8.61 % 14.74 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.